Quick Takeaways
- T. Rowe Price Investment Management, Inc. filed SCHEDULE 13G for APPLIED THERAPEUTICS INC COMMON STOCK (APLT).
- Disclosed ownership: 8.9%.
- Date of event: 31 Mar 2025.
T. Rowe Price Investment Management, Inc. - 31 Mar 2025 SCHEDULE 13G Report for APPLIED THERAPEUTICS INC COMMON STOCK (APLT)
- Filing Manager
- T. Rowe Price Investment Management, Inc.
- Reporting Manager
- T. Rowe Price Investment Management, Inc.
- Symbol
- APLT
- Shares outstanding
- 116,635,843 shares
- Disclosed Ownership
- 10,380,590 shares
- Ownership
- 8.9%
- Form type
- SCHEDULE 13G
- Filing time
- 07 May 2025, 10:19:02 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 07 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"T. Rowe Price Investment Management, Inc. disclosed 8.9% ownership in APPLIED THERAPEUTICS INC COMMON STOCK (APLT) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 May 2025, 10:19.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 8.9% | 10,380,590 | 10,380,590 | 0 | Ellen York | Vice President |